INSANGA

Insanga is a South Korean healthcare and life sciences company that pioneered the commercialization of medicinal bamboo salt (Juk-yeom). The company operates a dedicated Life Science Research Institute focused on scientifically validating the therapeutic properties of mineral-rich salt formulations in areas such as oncology, immunology, and metabolic health. Recently, Insanga has expanded its research into the pharmaceutical potential of bamboo salt components for treating metabolic disorders, including non-alcoholic steatohepatitis (NASH) and obesity. Publicly traded on the KOSDAQ exchange, the company maintains a diverse portfolio of functional foods, cosmetics, and wellness products rooted in traditional Korean medicinal principles modernized through evidence-based research. Its proprietary high-temperature processing technology serves as a platform for developing novel mineral-based therapeutic candidates.